DrugPatentWatch Database Preview

Litigation Details for In Re: BRCA1- and BRCA2- Based Hereditary Cancer Test Patent Litigation (D. Utah 2014)

« Back to Dashboard

In Re: BRCA1- and BRCA2- Based Hereditary Cancer Test Patent Litigation (D. Utah 2014)

Docket		Date Filed	2014-02-25
Court	District Court, D. Utah	Date Terminated	2015-03-09
Cause	35:0271 Patent Infringement	Assigned To	Robert James Shelby
Jury Demand	Both	Referred To
Parties	AARP; AMBRY GENETICS; AMERICAN CIVIL LIBERTIES UNION; AMERICAN CIVIL LIBERTIES UNION FOUNDATION OF UTAH; ASSOCIATION FOR MOLECULAR PATHOLOGY; BRCA1- AND BRCA2- BASED HEREDITARY CANCER TEST PATENT LITIGATION; BREAST CANCER ACTION; COUNSYL, INC; ENDORECHERCHE; GENE BY GENE; GENEDX; HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP; INVITAE CORPORATION; LABRORATORY CORPORATION OF AMERICA HOLDINGS; MDL PANEL; MYRIAD GENETICS; PATHWAY GENOMICS; PUBLIC PATENT FOUNDATION; QUEST DIAGNOSTICS; QUEST DIAGNOSTICS NICHOLS INSTITUTE; TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA; UNIVERSITY OF UTAH RESEARCH FOUNDATION
Patents	6,051,379; 6,083,698
Attorneys	Adam R. Brausa; Barbara A. Jones; Benjamin G. Jackson; Brady L. Rasmussen; Brent O. Hatch; Brook B. Bond; C. Kevin Speirs; Charles L. Roberts; Colin T. Kemp; Dana E. Vallera; Daniel Greene; Daniel Ravicher; Daralyn J. Durie; David G. Mangum; David Martinez; Edgar R. Cataxinos; Elizabeth M. Flanagan; Elizabeth Mary Butler; Emmett J. McMahon; Eric W. Hagen; Geoff D. Biegler; H. Dickson Burton; Hemant K. Sabharwal; Jared J. Braithwaite; Jeremiah B. Frueauf; Jess M. Krannich; John C. Low; John M. Mejia; Jonathan E. Singer; Joseph A. Walkowski; Josephine Young; Kira A. Davis; Kirke M. Hasson; Kristine E. Johnson; Larry R. Laycock; Lenora M. Lapidus; Lesli R. Gallagher; Leslie T. Grab; Limin Zheng; Mark A. Lemley; Mark M. Bettilyon; Martin R. Lueck; Matias Ferrario; Matthew B. McFarlane; Matthew S. Gordon; MDL Panel; Mica McKinney; Michael Henry Page; Michael K. Erickson; Michael R. McCarthy; Nathan D. Thomas; Nicholas Groombridge; Nirav N. Desai; Paul D. Tripodi , II; Rebecca Fett; Rebecca L. Shult; Richard E. Mrazik; Richard L. Blaylock; Rita M. Cornish; Robert S. Clark; Sandra S. Park; Susan A. Cahoon; Tadahiro Kaburaki; Timothy Chen Saulsbury; Vanessa Lefort; William G. Gaede , III
Firms	Aarp Foundation Litigation; Hatch James Dodge Pc; Jones Waldo Holbrook & McDonough (SLC); Kilpatrick Townsend & Stockton LLP; Kilpatrick Townsend & Stockton LLP(GA); McDermott Will & Emery (Ca); McDermott Will & Emery LLP; Public Patent Foundation, Cardozo School of Law; Sterne Kessler Goldstein & Fox PLLC; Wasatch-Ip
Link to Docket	External link to docket

Details for In Re: BRCA1- and BRCA2- Based Hereditary Cancer Test Patent Litigation (D. Utah 2014)

Date Filed	Document No.	Description	Snippet	Link To Document
2014-08-07	133		LPR 2.3 Contentions Eleven Claims for U.S. Patent No. 6,051,379 and Memorandum in Support filed by MDL Notice… BRCA1- and BRCA2- Based Hereditary Cancer Test Patent Litigation 25 February 2014 9… 9 March 2015 2:14-md-02510 830 Patent Both District Court, D. Utah D. Utah	External link to document
2014-08-13	138		LPR 2.3 Contentions Eleven Claims for U.S. Patent No. 6,051,379 in case 2:14-md-02510-RJS. Signed by Judge… BRCA1- and BRCA2- Based Hereditary Cancer Test Patent Litigation 25 February 2014 9… 9 March 2015 2:14-md-02510 830 Patent Both District Court, D. Utah D. Utah	External link to document
2014-05-06	53		the “’109 patent”); and 6,051,379 (the “’379 patent”) (collectively, the “patents-in-suit”). Myriad further… 54. United States Patent No. 6,051,379 (the “’379 Patent”) was duly and legally issued … Myriad owns United States Patent Nos. 5,654,155; 5,750,400; 6,051,379; 6,951,721; 7,250,497; 6,083,698…United States Patent Nos. 5,709,999; 5,747,282; 5,753,441; 5,837,492; 6,033,857; 6,051,379; 6,951,721; … (Infringement of United States Patent No. 6,051,379) 53. Myriad repeats	External link to document